nodes	percent_of_prediction	percent_of_DWPC	metapath
Meprobamate—Proctitis—Riluzole—amyotrophic lateral sclerosis	0.081	0.163	CcSEcCtD
Meprobamate—Thrombocytopenic purpura—Riluzole—amyotrophic lateral sclerosis	0.0422	0.0846	CcSEcCtD
Meprobamate—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.024	0.0482	CcSEcCtD
Meprobamate—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.0209	0.042	CcSEcCtD
Meprobamate—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.0186	0.0373	CcSEcCtD
Meprobamate—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.0179	0.0359	CcSEcCtD
Meprobamate—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.017	0.0341	CcSEcCtD
Meprobamate—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.0168	0.0338	CcSEcCtD
Meprobamate—GABRA6—hindbrain—amyotrophic lateral sclerosis	0.0165	0.0781	CbGeAlD
Meprobamate—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.0161	0.0322	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.0152	0.0305	CcSEcCtD
Meprobamate—Purpura—Riluzole—amyotrophic lateral sclerosis	0.0149	0.0299	CcSEcCtD
Meprobamate—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.0135	0.0271	CcSEcCtD
Meprobamate—GABRA2—hindbrain—amyotrophic lateral sclerosis	0.0111	0.0525	CbGeAlD
Meprobamate—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0216	CcSEcCtD
Meprobamate—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.0107	0.0508	CbGeAlD
Meprobamate—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0207	CcSEcCtD
Meprobamate—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00979	0.0196	CcSEcCtD
Meprobamate—GABRA6—brainstem—amyotrophic lateral sclerosis	0.00948	0.0448	CbGeAlD
Meprobamate—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00939	0.0188	CcSEcCtD
Meprobamate—Chills—Riluzole—amyotrophic lateral sclerosis	0.00891	0.0179	CcSEcCtD
Meprobamate—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00888	0.0178	CcSEcCtD
Meprobamate—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00795	0.0159	CcSEcCtD
Meprobamate—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.0079	0.0159	CcSEcCtD
Meprobamate—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00777	0.0156	CcSEcCtD
Meprobamate—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00776	0.0156	CcSEcCtD
Meprobamate—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00774	0.0155	CcSEcCtD
Meprobamate—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00764	0.0153	CcSEcCtD
Meprobamate—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.0076	0.0152	CcSEcCtD
Meprobamate—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00706	0.0142	CcSEcCtD
Meprobamate—Shock—Riluzole—amyotrophic lateral sclerosis	0.00694	0.0139	CcSEcCtD
Meprobamate—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00689	0.0138	CcSEcCtD
Meprobamate—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.0066	0.0132	CcSEcCtD
Meprobamate—GABRA2—brainstem—amyotrophic lateral sclerosis	0.00637	0.0301	CbGeAlD
Meprobamate—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00634	0.0127	CcSEcCtD
Meprobamate—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00628	0.0126	CcSEcCtD
Meprobamate—GABRA1—brainstem—amyotrophic lateral sclerosis	0.00616	0.0291	CbGeAlD
Meprobamate—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00558	0.0112	CcSEcCtD
Meprobamate—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.0052	0.0104	CcSEcCtD
Meprobamate—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00506	0.0102	CcSEcCtD
Meprobamate—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00499	0.01	CcSEcCtD
Meprobamate—GABRA6—nervous system—amyotrophic lateral sclerosis	0.00497	0.0235	CbGeAlD
Meprobamate—GABRG2—medulla oblongata—amyotrophic lateral sclerosis	0.00486	0.023	CbGeAlD
Meprobamate—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00483	0.00969	CcSEcCtD
Meprobamate—GABRA5—nervous system—amyotrophic lateral sclerosis	0.00482	0.0228	CbGeAlD
Meprobamate—GABRA6—central nervous system—amyotrophic lateral sclerosis	0.00478	0.0226	CbGeAlD
Meprobamate—GABRA6—cerebellum—amyotrophic lateral sclerosis	0.00467	0.0221	CbGeAlD
Meprobamate—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00467	0.00936	CcSEcCtD
Meprobamate—GABRA5—central nervous system—amyotrophic lateral sclerosis	0.00464	0.0219	CbGeAlD
Meprobamate—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00449	0.009	CcSEcCtD
Meprobamate—GABRA3—nervous system—amyotrophic lateral sclerosis	0.00448	0.0212	CbGeAlD
Meprobamate—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00445	0.00892	CcSEcCtD
Meprobamate—Headache—Riluzole—amyotrophic lateral sclerosis	0.00442	0.00887	CcSEcCtD
Meprobamate—GABRA4—nervous system—amyotrophic lateral sclerosis	0.00437	0.0206	CbGeAlD
Meprobamate—GABRG2—spinal cord—amyotrophic lateral sclerosis	0.00434	0.0205	CbGeAlD
Meprobamate—GABRA3—central nervous system—amyotrophic lateral sclerosis	0.00432	0.0204	CbGeAlD
Meprobamate—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.0043	0.0203	CbGeAlD
Meprobamate—GABRA4—central nervous system—amyotrophic lateral sclerosis	0.00421	0.0199	CbGeAlD
Meprobamate—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00419	0.00841	CcSEcCtD
Meprobamate—GABRA4—cerebellum—amyotrophic lateral sclerosis	0.00411	0.0194	CbGeAlD
Meprobamate—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.00383	0.0181	CbGeAlD
Meprobamate—GABRA6—brain—amyotrophic lateral sclerosis	0.0038	0.0179	CbGeAlD
Meprobamate—GABRB3—medulla oblongata—amyotrophic lateral sclerosis	0.00374	0.0176	CbGeAlD
Meprobamate—GABRA5—brain—amyotrophic lateral sclerosis	0.00368	0.0174	CbGeAlD
Meprobamate—GABRG2—nervous system—amyotrophic lateral sclerosis	0.00366	0.0173	CbGeAlD
Meprobamate—GABRG2—central nervous system—amyotrophic lateral sclerosis	0.00352	0.0166	CbGeAlD
Meprobamate—GABRG2—cerebellum—amyotrophic lateral sclerosis	0.00344	0.0163	CbGeAlD
Meprobamate—GABRA3—brain—amyotrophic lateral sclerosis	0.00343	0.0162	CbGeAlD
Meprobamate—GABRA4—brain—amyotrophic lateral sclerosis	0.00334	0.0158	CbGeAlD
Meprobamate—GABRA2—nervous system—amyotrophic lateral sclerosis	0.00334	0.0158	CbGeAlD
Meprobamate—GABRB3—spinal cord—amyotrophic lateral sclerosis	0.00333	0.0157	CbGeAlD
Meprobamate—GABRA1—nervous system—amyotrophic lateral sclerosis	0.00323	0.0152	CbGeAlD
Meprobamate—GABRA2—central nervous system—amyotrophic lateral sclerosis	0.00322	0.0152	CbGeAlD
Meprobamate—GABRA2—cerebellum—amyotrophic lateral sclerosis	0.00314	0.0148	CbGeAlD
Meprobamate—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.00311	0.0147	CbGeAlD
Meprobamate—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.00304	0.0143	CbGeAlD
Meprobamate—GABRB3—nervous system—amyotrophic lateral sclerosis	0.00281	0.0133	CbGeAlD
Meprobamate—GABRG2—brain—amyotrophic lateral sclerosis	0.00279	0.0132	CbGeAlD
Meprobamate—GABRB3—central nervous system—amyotrophic lateral sclerosis	0.0027	0.0128	CbGeAlD
Meprobamate—GABRB3—cerebellum—amyotrophic lateral sclerosis	0.00264	0.0125	CbGeAlD
Meprobamate—GABRA2—brain—amyotrophic lateral sclerosis	0.00255	0.0121	CbGeAlD
Meprobamate—GABRA1—brain—amyotrophic lateral sclerosis	0.00247	0.0117	CbGeAlD
Meprobamate—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.00238	0.0112	CbGeAlD
Meprobamate—GABRB3—brain—amyotrophic lateral sclerosis	0.00215	0.0101	CbGeAlD
Meprobamate—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.00212	0.01	CbGeAlD
Meprobamate—ABCB1—embryo—amyotrophic lateral sclerosis	0.00212	0.01	CbGeAlD
Meprobamate—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.00179	0.00844	CbGeAlD
Meprobamate—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.00172	0.00812	CbGeAlD
Meprobamate—GABRA4—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.0017	0.00586	CbGpPWpGaD
Meprobamate—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.00168	0.00794	CbGeAlD
Meprobamate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00165	0.0057	CbGpPWpGaD
Meprobamate—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00164	0.00565	CbGpPWpGaD
Meprobamate—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00161	0.00555	CbGpPWpGaD
Meprobamate—GABRA6—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00159	0.00548	CbGpPWpGaD
Meprobamate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00158	0.00545	CbGpPWpGaD
Meprobamate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00157	0.00542	CbGpPWpGaD
Meprobamate—GABRA4—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00157	0.00541	CbGpPWpGaD
Meprobamate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00154	0.00532	CbGpPWpGaD
Meprobamate—GABRA6—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00153	0.00529	CbGpPWpGaD
Meprobamate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00152	0.00526	CbGpPWpGaD
Meprobamate—GABRA4—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00151	0.00523	CbGpPWpGaD
Meprobamate—GABRA5—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00151	0.00521	CbGpPWpGaD
Meprobamate—GABRA3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00148	0.00512	CbGpPWpGaD
Meprobamate—GABRA2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00146	0.00503	CbGpPWpGaD
Meprobamate—GABRB3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00145	0.00499	CbGpPWpGaD
Meprobamate—GABRG2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00142	0.0049	CbGpPWpGaD
Meprobamate—GABRA6—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.0014	0.00484	CbGpPWpGaD
Meprobamate—GABRA5—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00139	0.00481	CbGpPWpGaD
Meprobamate—GABRA4—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00138	0.00478	CbGpPWpGaD
Meprobamate—GABRA3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00137	0.00472	CbGpPWpGaD
Meprobamate—CYP2E1—brain—amyotrophic lateral sclerosis	0.00137	0.00645	CbGeAlD
Meprobamate—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.00135	0.0064	CbGeAlD
Meprobamate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00135	0.00465	CbGpPWpGaD
Meprobamate—GABRA5—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00135	0.00464	CbGpPWpGaD
Meprobamate—GABRA2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00134	0.00464	CbGpPWpGaD
Meprobamate—GABRB3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00134	0.00461	CbGpPWpGaD
Meprobamate—GABRA3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00132	0.00456	CbGpPWpGaD
Meprobamate—GABRA6—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00132	0.00455	CbGpPWpGaD
Meprobamate—GABRG2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00131	0.00453	CbGpPWpGaD
Meprobamate—GABRA6—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.0013	0.0045	CbGpPWpGaD
Meprobamate—GABRA6—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.0013	0.0045	CbGpPWpGaD
Meprobamate—GABRA4—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.0013	0.00449	CbGpPWpGaD
Meprobamate—GABRA2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.0013	0.00448	CbGpPWpGaD
Meprobamate—GABRB3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00129	0.00445	CbGpPWpGaD
Meprobamate—GABRA4—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00129	0.00444	CbGpPWpGaD
Meprobamate—GABRA4—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00129	0.00444	CbGpPWpGaD
Meprobamate—GABRG2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00127	0.00437	CbGpPWpGaD
Meprobamate—GABRA1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00124	0.00429	CbGpPWpGaD
Meprobamate—GABRB3—BDNF signaling pathway—MAPT—amyotrophic lateral sclerosis	0.00124	0.00428	CbGpPWpGaD
Meprobamate—GABRA5—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00123	0.00425	CbGpPWpGaD
Meprobamate—GABRA6—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00122	0.0042	CbGpPWpGaD
Meprobamate—GABRA3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00121	0.00417	CbGpPWpGaD
Meprobamate—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.00121	0.0057	CbGeAlD
Meprobamate—GABRA4—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.0012	0.00415	CbGpPWpGaD
Meprobamate—GABRA2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00119	0.0041	CbGpPWpGaD
Meprobamate—GABRB3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00118	0.00407	CbGpPWpGaD
Meprobamate—GABRA6—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00117	0.00406	CbGpPWpGaD
Meprobamate—GABRA6—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00116	0.00401	CbGpPWpGaD
Meprobamate—GABRA4—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00116	0.004	CbGpPWpGaD
Meprobamate—GABRG2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00116	0.004	CbGpPWpGaD
Meprobamate—GABRA5—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00116	0.00399	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00115	0.00396	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00115	0.00396	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00115	0.00396	CbGpPWpGaD
Meprobamate—GABRA4—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00115	0.00396	CbGpPWpGaD
Meprobamate—GABRA1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00115	0.00396	CbGpPWpGaD
Meprobamate—GABRA5—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00114	0.00395	CbGpPWpGaD
Meprobamate—GABRA5—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00114	0.00395	CbGpPWpGaD
Meprobamate—GABRA3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00114	0.00392	CbGpPWpGaD
Meprobamate—GABRA3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00112	0.00388	CbGpPWpGaD
Meprobamate—GABRA3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00112	0.00388	CbGpPWpGaD
Meprobamate—GABRA2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00112	0.00385	CbGpPWpGaD
Meprobamate—GABRB3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00111	0.00383	CbGpPWpGaD
Meprobamate—GABRA1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00111	0.00382	CbGpPWpGaD
Meprobamate—GABRA2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.0011	0.00381	CbGpPWpGaD
Meprobamate—GABRA2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.0011	0.00381	CbGpPWpGaD
Meprobamate—GABRB3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.0011	0.00379	CbGpPWpGaD
Meprobamate—GABRB3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.0011	0.00379	CbGpPWpGaD
Meprobamate—GABRG2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00109	0.00376	CbGpPWpGaD
Meprobamate—GABRG2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00108	0.00372	CbGpPWpGaD
Meprobamate—GABRG2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00108	0.00372	CbGpPWpGaD
Meprobamate—GABRA6—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00107	0.00371	CbGpPWpGaD
Meprobamate—GABRA5—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00107	0.00368	CbGpPWpGaD
Meprobamate—GABRA4—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00106	0.00366	CbGpPWpGaD
Meprobamate—GABRA3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00105	0.00362	CbGpPWpGaD
Meprobamate—GABRA5—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00103	0.00356	CbGpPWpGaD
Meprobamate—GABRA2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00103	0.00355	CbGpPWpGaD
Meprobamate—GABRB3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00102	0.00353	CbGpPWpGaD
Meprobamate—GABRA5—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00102	0.00352	CbGpPWpGaD
Meprobamate—ABCB1—nervous system—amyotrophic lateral sclerosis	0.00102	0.00481	CbGeAlD
Meprobamate—GABRA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00101	0.00349	CbGpPWpGaD
Meprobamate—GABRA3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00101	0.00349	CbGpPWpGaD
Meprobamate—GABRG2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.001	0.00347	CbGpPWpGaD
Meprobamate—GABRA3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.001	0.00346	CbGpPWpGaD
Meprobamate—GABRA6—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000999	0.00345	CbGpPWpGaD
Meprobamate—GABRA6—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000999	0.00345	CbGpPWpGaD
Meprobamate—GABRA2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000995	0.00343	CbGpPWpGaD
Meprobamate—GABRB3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000988	0.00341	CbGpPWpGaD
Meprobamate—GABRA4—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000986	0.0034	CbGpPWpGaD
Meprobamate—GABRA4—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000986	0.0034	CbGpPWpGaD
Meprobamate—GABRA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000984	0.0034	CbGpPWpGaD
Meprobamate—GABRA6—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00098	0.00338	CbGpPWpGaD
Meprobamate—GABRB3—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.00098	0.00338	CbGpPWpGaD
Meprobamate—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000979	0.00463	CbGeAlD
Meprobamate—GABRB3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000978	0.00337	CbGpPWpGaD
Meprobamate—GABRG2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00097	0.00335	CbGpPWpGaD
Meprobamate—GABRA4—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000968	0.00334	CbGpPWpGaD
Meprobamate—GABRG2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00096	0.00331	CbGpPWpGaD
Meprobamate—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000957	0.00452	CbGeAlD
Meprobamate—GABRA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000952	0.00328	CbGpPWpGaD
Meprobamate—GABRA5—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000943	0.00325	CbGpPWpGaD
Meprobamate—GABRA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000941	0.00325	CbGpPWpGaD
Meprobamate—GABRA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000941	0.00325	CbGpPWpGaD
Meprobamate—GABRA3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000926	0.0032	CbGpPWpGaD
Meprobamate—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000921	0.00318	CbGpPWpGaD
Meprobamate—GABRA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00091	0.00314	CbGpPWpGaD
Meprobamate—GABRB3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000904	0.00312	CbGpPWpGaD
Meprobamate—GABRA6—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00089	0.00307	CbGpPWpGaD
Meprobamate—GABRG2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000888	0.00306	CbGpPWpGaD
Meprobamate—GABRA4—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000879	0.00303	CbGpPWpGaD
Meprobamate—GABRA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000878	0.00303	CbGpPWpGaD
Meprobamate—GABRA5—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000876	0.00303	CbGpPWpGaD
Meprobamate—GABRA5—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000876	0.00303	CbGpPWpGaD
Meprobamate—GABRA3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000861	0.00297	CbGpPWpGaD
Meprobamate—GABRA3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000861	0.00297	CbGpPWpGaD
Meprobamate—GABRA5—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00086	0.00297	CbGpPWpGaD
Meprobamate—CYP2E1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00085	0.00293	CbGpPWpGaD
Meprobamate—GABRA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000848	0.00293	CbGpPWpGaD
Meprobamate—GABRA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000846	0.00292	CbGpPWpGaD
Meprobamate—GABRA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000846	0.00292	CbGpPWpGaD
Meprobamate—GABRA3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000845	0.00291	CbGpPWpGaD
Meprobamate—GABRB3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00084	0.0029	CbGpPWpGaD
Meprobamate—GABRB3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00084	0.0029	CbGpPWpGaD
Meprobamate—GABRA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000839	0.0029	CbGpPWpGaD
Meprobamate—GABRA2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00083	0.00286	CbGpPWpGaD
Meprobamate—GABRG2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000825	0.00285	CbGpPWpGaD
Meprobamate—GABRG2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000825	0.00285	CbGpPWpGaD
Meprobamate—GABRB3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000825	0.00285	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00081	0.00279	CbGpPWpGaD
Meprobamate—GABRA5—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000781	0.0027	CbGpPWpGaD
Meprobamate—ABCB1—brain—amyotrophic lateral sclerosis	0.000777	0.00367	CbGeAlD
Meprobamate—GABRA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000776	0.00268	CbGpPWpGaD
Meprobamate—GABRA3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000767	0.00265	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00076	0.00262	CbGpPWpGaD
Meprobamate—GABRA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000754	0.0026	CbGpPWpGaD
Meprobamate—GABRB3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000749	0.00258	CbGpPWpGaD
Meprobamate—GABRB3—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000738	0.00255	CbGpPWpGaD
Meprobamate—GABRG2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000735	0.00254	CbGpPWpGaD
Meprobamate—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000724	0.0025	CbGpPWpGaD
Meprobamate—GABRA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000721	0.00249	CbGpPWpGaD
Meprobamate—GABRA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000721	0.00249	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000708	0.00244	CbGpPWpGaD
Meprobamate—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000655	0.00226	CbGpPWpGaD
Meprobamate—GABRA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000643	0.00222	CbGpPWpGaD
Meprobamate—GABRA6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000632	0.00218	CbGpPWpGaD
Meprobamate—GABRA4—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000624	0.00215	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00062	0.00214	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.000609	0.0021	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000594	0.00205	CbGpPWpGaD
Meprobamate—GABRA5—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000554	0.00191	CbGpPWpGaD
Meprobamate—GABRA3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000544	0.00188	CbGpPWpGaD
Meprobamate—GABRA6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000537	0.00185	CbGpPWpGaD
Meprobamate—GABRA6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000537	0.00185	CbGpPWpGaD
Meprobamate—GABRA2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000535	0.00185	CbGpPWpGaD
Meprobamate—GABRB3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000531	0.00183	CbGpPWpGaD
Meprobamate—GABRA4—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00053	0.00183	CbGpPWpGaD
Meprobamate—GABRA4—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00053	0.00183	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000522	0.0018	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000505	0.00174	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.00049	0.00169	CbGpPWpGaD
Meprobamate—GABRA6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000479	0.00165	CbGpPWpGaD
Meprobamate—GABRA4—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000473	0.00163	CbGpPWpGaD
Meprobamate—GABRA5—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000471	0.00163	CbGpPWpGaD
Meprobamate—GABRA5—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000471	0.00163	CbGpPWpGaD
Meprobamate—GABRA3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000463	0.0016	CbGpPWpGaD
Meprobamate—GABRA3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000463	0.0016	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000462	0.00159	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000456	0.00157	CbGpPWpGaD
Meprobamate—GABRA2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000455	0.00157	CbGpPWpGaD
Meprobamate—GABRA2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000455	0.00157	CbGpPWpGaD
Meprobamate—GABRB3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000452	0.00156	CbGpPWpGaD
Meprobamate—GABRB3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000452	0.00156	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000444	0.00153	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000444	0.00153	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	0.000433	0.0015	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000429	0.00148	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000426	0.00147	CbGpPWpGaD
Meprobamate—GABRA5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00042	0.00145	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000413	0.00143	CbGpPWpGaD
Meprobamate—GABRA3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000412	0.00142	CbGpPWpGaD
Meprobamate—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000408	0.00141	CbGpPWpGaD
Meprobamate—GABRA2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000405	0.0014	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000403	0.00139	CbGpPWpGaD
Meprobamate—GABRB3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000403	0.00139	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000395	0.00136	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000389	0.00134	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000388	0.00134	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000388	0.00134	CbGpPWpGaD
Meprobamate—CYP2E1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00038	0.00131	CbGpPWpGaD
Meprobamate—CYP2E1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000375	0.00129	CbGpPWpGaD
Meprobamate—GABRB3—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000369	0.00127	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000355	0.00123	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000346	0.00119	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000301	0.00104	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000297	0.00102	CbGpPWpGaD
Meprobamate—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000293	0.00101	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000291	0.00101	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000291	0.00101	CbGpPWpGaD
Meprobamate—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000289	0.000998	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000277	0.000954	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000266	0.00092	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	0.000257	0.000886	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000253	0.000875	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000252	0.000869	CbGpPWpGaD
Meprobamate—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000251	0.000868	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000248	0.000855	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000242	0.000835	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000233	0.000804	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000229	0.000789	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000225	0.000776	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000225	0.000776	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000219	0.000757	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000219	0.000757	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	0.000218	0.000751	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000211	0.000727	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00021	0.000723	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000206	0.00071	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000201	0.000693	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000195	0.000671	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000195	0.000671	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000191	0.00066	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000187	0.000644	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00018	0.00062	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000175	0.000605	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000173	0.000598	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000164	0.000568	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	0.000163	0.000561	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00016	0.000551	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000159	0.000547	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000147	0.000508	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000136	0.000471	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000127	0.000437	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000123	0.000425	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000121	0.000418	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00012	0.000415	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	0.000114	0.000392	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000111	0.000383	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000107	0.000371	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000104	0.000357	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	9.33e-05	0.000322	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	9.11e-05	0.000314	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.52e-05	0.000294	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	8.12e-05	0.00028	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.5e-05	0.000224	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.98e-05	0.000206	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.84e-05	0.000201	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.02e-05	0.000173	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	4.92e-05	0.00017	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.9e-05	0.000169	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.61e-05	0.000159	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.5e-05	0.000155	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	3.79e-05	0.000131	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	3.7e-05	0.000128	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.37e-05	0.000116	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.6e-05	8.97e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.54e-05	8.75e-05	CbGpPWpGaD
